Intravitreal ranibizumab therapy for retinal arterial macroaneurysm.
نویسندگان
چکیده
AIM To evaluate the anatomic and functional results of intravitreal ranibizumab injection for treatment of symptomatic retinal arterial macroaneurysm (RAM). MATERIALS AND METHODS A series of seven patients (seven eyes) who had been diagnosed with symptomatic RAM were assessed by comprehensive ophthalmologic examination, fluorescein angiography (FA), optical coherence tomography (OCT), and indocyanine green angiography (ICGA). All patients were treated by intravitreal ranibizumab injection within one week of diagnosis and retreated upon evidence of persistent serous detachment or hemorrhage involving the macula on OCT. Anatomical recovery was examined by FA, OCT, and ICGA. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were evaluated using the Snellen chart and optical coherence tomography, respectively, at baseline; at 1, 3, and 6 months; and at the final visit. The BCVA and CMT values at baseline and the final visit were compared using the Wilcoxon signed rank test and determination of logarithm of the minimal angle of resolution (logMAR) of BCVA value. RESULTS Over a mean follow-up period of 10.86 ± 5.4 months, significant visual and anatomical recovery was observed, with visual acuity improving by three or more lines in all seven patients. The mean logMAR of BCVA improved from 1.09 ± 0.60 to 0.16 ± 0.16 (p = 0.018) and mean CMT decreased from 427.5 ± 132.4 μm to 208.7 ± 23.1 μm (P = 0.018). No complications were observed with intravitreal ranibizumab injection. CONCLUSION İntravitreal ranibizumab is an effective therapy for symptomatic RAM, improving BCVA and decreasing CMT.
منابع مشابه
Succesful Treatment of a Patient with Retinal Arterial Macroaneurysm with İntravitreal Ranibizumab Injection: Case Report
Purpose: To present the effect of intravitreal ranibizumab (Lucentis®) therapy in a patient suffering from symptomatic retinal arterial macroaneurysm. Methods: Case report. A 67-year-old female patient was diagnosed with retinal macroaneurysm of the superior temporal artery with serous macular detachment and hemorrhage Intravitreal montly three 3 injection of ranibizumab was initiated to the pa...
متن کاملIntravitreal Vascular Endothelium Growth Factor Inhibitors for Retinal Macroaneurysms
Last year our group published the case of a foveal longstanding retinal macroaneurysm successfully treated with intravitreal ranibizumab. Few studies have also reported the safety and effectiveness of intravitreal vascular endothelium growth factor inhibitors (anti-VEGF) in the management of symptomatic retinal arterial macroaneurysms. In this commentary we make a brief review of this clinical ...
متن کاملFoveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
PURPOSE We report a case of a foveal macroaneurysm with long-standing macular edema in a rare location, successfully treated with intravitreal ranibizumab. METHODS We report the case of a 52-year-old man with left eye long-term visual loss due to macular edema caused by a retinal macroaneurysm, localized about 400 μm from the center of the fovea, and its response to 6 monthly ranibizumab intr...
متن کاملLong-Term Follow-Up of Intravitreal Bevacizumab in Retinal Arterial Macroaneurysm: A Case Report
PURPOSE To present the long-term effect of intravitreal bevacizumab (Avastin(®)) therapy in a patient suffering from retinal arterial macroaneurysm. METHODS Case report of a 72-year-old female diagnosed with retinal macroaneurysm in the superior temporal artery leading to macular edema. Functional and morphological data at baseline, 4 weeks, 2 months, and 13 months following treatment with tw...
متن کاملIntravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.
PURPOSE To evaluate the therapeutic effect of intravitreal bevacizumab injection for symptomatic retinal arterial macroaneurysm. DESIGN Retrospective interventional case series. METHODS The study included 23 patients (23 eyes) with symptomatic retinal arterial macroaneurysm. They were categorized according to treatment method into 2 groups: an intravitreal bevacizumab-treated group (11 eyes...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- International journal of clinical and experimental medicine
دوره 8 7 شماره
صفحات -
تاریخ انتشار 2015